abstract |
The present invention relates to RNAi agents that target the PCSK9 gene, such as double-stranded RNAi agents, and methods of using such RNAi agents to inhibit the expression of PCSK9 and lipid disorders such as hyperlipidemia. It is related with the treatment method of the subject. |